Mild decrease in estimated glomerular filtration rate and proteinuria are associated with all-cause and cardiovascular mortality in the general population

Nephrology Dialysis Transplantation

Volumn 27, Issue 6, 2012, Pages 2284-2290

  Oh, Se Won ^a   Baek, Seon Ha ^b   Kim, Yong Chul ^b   Goo, Ho Suk ^c   Heo, Nam Ju ^b   Na, Ki Young ^a,b   Chae, Dong Wan ^a,b   Kim, Suhnggwon ^b,d   Chin, Ho Jun ^a,b,d  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University   (South Korea)

^c Inje University College of Medicine   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

All cause mortality; Cardiovascular mortality; General population; Glomerular filtration rate; Proteinuria

Indexed keywords

CREATININE;

ADULT; ADVERSE OUTCOME; ALL CAUSE MORTALITY; ARTICLE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HAZARD RATIO; HUMAN; KIDNEY DISEASE; KOREA; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MORTALITY; POPULATION; PRIORITY JOURNAL; PROTEINURIA; TERTIARY HEALTH CARE; URINALYSIS;

ADULT; CARDIOVASCULAR DISEASES; CREATININE; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS; PROTEINURIA; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; URINALYSIS; YOUNG ADULT;

EID: 84861903145     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr622     Document Type: Article

References (30)

1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266
2. Levey AS, Eckardt KU, Tsukamoto Y et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089-2100
3. Gansevoort RT, de Jong PE. The case for using albuminuria in staging chronic kidney disease. J Am Soc Nephrol 2009; 20: 465-468
4. Bauer C, Melamed ML, Hostetter TH. Staging of chronic kidney disease: time for a course correction. J Am Soc Nephrol 2008; 19: 844-846
5. Glassock RJ, Winearls C. An epidemic of chronic kidney disease: fact or fiction? Nephrol Dial Transplant 2008; 23: 1117-1123
6. Wetzels JF, Willems HL, den Heijer M. Age-and gender-specific reference values of estimated glomerular filtration rate in a Caucasian population: results of the Nijmegen Biomedical Study. Kidney Int 2008; 73: 657-658
7. Winearls CG, Glassock RJ. Dissecting and refining the staging of chronic kidney disease. Kidney Int 2009; 75: 1009-1014
8. Levey AS, de Jong PE, Coresh J et al. The definition, classification and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int 2011; 80: 17-28
9. The Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality: a collaborative meta-analysis of general population cohorts. Lancet 2010; 375: 2073-2081
10. van der Velde M, Matsushita K, Coresh J et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int 2011; 79: 1341-1352
11. Gansevoort RT, Matsushita K, van der Velde M et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 2011; 80: 93-104
12. Astor BC, Matsushita K, Gansevoort RT et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int 2011; 79: 1331-1340
13. Levey AS, Coresh J, Greene T et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.Ann InternMed 2006; 145: 247-254
14. Lee CS, Cha RH, Lim YH et al. Ethnic coefficients for glomerular filtration rate estimation by the Modification of Diet in Renal Disease study equations in the Korean population. J Korean Med Sci 2010; 25: 1616-1625
15. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752
16. Korean Statistical Information Service. http://kosis.kr/eng/database/ database-001000.jsp?listid/B&subtitle/Population,%20Household (5 September 2011, date last accessed)
17. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047
18. Levey AS, Stevens LA, Coresh J. Conceptual model of CKD: applications and implications. Am J Kidney Dis 2009; 53: S4-S16
19. Sarnak MJ, Levey AS, Schoolwerth AC et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154-2169
20. Hemmelgarn BR, Manns BJ, Lloyd A et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA 2010; 303: 423-429
21. Hallan SI, Ritz E, Lydersen S et al. Combining GFR and albuminuria to classify CKD improves prediction of ESRD. J Am Soc Nephrol 2009; 20: 1069-1077
22. Stevens LA, Levey AS. Clinical implications for estimating equations for glomerular filtration rate. Ann Intern Med 2004; 141: 959-961
23. Quinn MP, Rainey A, Cairns KJ et al. The practical implications of using standardized estimation equations in calculating the prevalence of chronic kidney disease. Nephrol Dial Transplant 2008; 23: 542-548
24. Stevens LA, Coresh J, Greene T et al. Assessing kidney function: measured and estimated glomerular filtration rate. N Engl J Med 2006; 354: 2473-2483
25. World Health Organization. http://www.who.int/mediacentre/factsheets/ fs310/en/(5 September 2011, date last accessed)
26. Lee SW, Kim YC, Oh SW et al. Trends in the prevalence of chronic kidney disease, other chronic diseases and health-related behaviors in an adult Korean population: data from the Korea National Health and Nutrition Examination Survey (KNHANES). Nephrol Dial Transplant 2012; 27: 2156-2161
27. Evenepoel P, Meijers B, Viaene L et al. Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism. Clin J Am Soc Nephrol 2010; 5: 1268-1276
28. Yilmaz MI, Sonmez A, Saglam M et al. FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease. Kidney Int 2010; 78: 679-685
29. Kanbay M, Nicoleta M, Selcoki Y et al. Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease. Clin J Am Soc Nephrol 2010; 5: 1780-1786
30. Edwards NC, Ferro CJ, Townend JN et al. Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: a pattern resembling heart failure with preserved ejection fraction. Heart 2008; 94: 1038-1043